Clinical Trials
8
Trial Phases
4 Phases
Drug Approvals
2
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials
A Study of Rituximab Versus Iodine I 131 Tositumomab Therapy for Patients With Non-Hodgkin's Lymphoma
- Conditions
- Non-Hodgkin's Lymphoma
- First Posted Date
- 2004-03-03
- Last Posted Date
- 2005-11-09
- Lead Sponsor
- Corixa Corporation
- Target Recruit Count
- 506
- Registration Number
- NCT00078598
- Locations
- 🇺🇸
Northside Hospital, Atlanta, Georgia, United States
🇺🇸Medical Oncology/Hematology Associates, Dayton, Ohio, United States
🇺🇸Madigan Army Medical Center, Tacoma, Washington, United States
Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung Cancer
- Conditions
- Non-Small Cell Lung Cancer
- First Posted Date
- 2003-06-19
- Last Posted Date
- 2006-12-06
- Lead Sponsor
- Corixa Corporation
- Target Recruit Count
- 9
- Registration Number
- NCT00062907
- Locations
- 🇺🇸
Cancer Centers of Florida, Ocoee, Florida, United States
🇺🇸Mary Crowley Medical Research Clinic, Dallas, Texas, United States
🇺🇸Tyler Cancer Center, Tyler, Texas, United States
Expanded Access Study of Iodine-131 Anti-B1 Antibody
- Conditions
- Non-Hodgkin's Lymphoma
- First Posted Date
- 2001-08-20
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Corixa Corporation
- Registration Number
- NCT00022958
- Locations
- 🇺🇸
Central Recruiting Information, South San Francisco, California, United States
Safety and Efficacy of Iodine-131 Anti-B1 Antibody for Intermediate Grade Non-Hodgkin's Lymphoma Following First Line CHOP
- Conditions
- Non-Hodgkin's Lymphoma
- First Posted Date
- 2001-08-20
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Corixa Corporation
- Registration Number
- NCT00022932
- Locations
- 🇺🇸
Rush Medical Center, Chicago, Illinois, United States
🇺🇸Tufts New England Medical Center, Boston, Massachusetts, United States
🇺🇸Cornell Medical Center, New York, New York, United States
Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody Plus CHOP For Untreated Mantle Cell Lymphoma
- Conditions
- Mantle Cell Lymphoma
- First Posted Date
- 2001-08-20
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Corixa Corporation
- Registration Number
- NCT00022945
- Locations
- 🇺🇸
Rush-Presbyterian-St. Lukes Medical Center, Chicago, Illinois, United States
🇺🇸Memorial Sloan-Kettering Cancer Center, New York, New York, United States
🇺🇸Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
- Prev
- 1
- 2
- Next